These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 33055081)
21. Your help is needed in the fight against COVID-19: Please contribute to the COVID-19 Global Rheumatology Alliance registry. Int J Rheum Dis; 2021 Feb; 24(2):286. PubMed ID: 33523563 [No Abstract] [Full Text] [Related]
22. Prevalence of COVID-19 among patients with rheumatic diseases: the need to await results from large collaborative studies. Response to: 'COVID-19 pneumonia in a large cohort of patients treated with biological and targeted synthetic antirheumatic drugs' by Conticini Monti S; Montecucco C Ann Rheum Dis; 2021 Feb; 80(2):e15. PubMed ID: 32414805 [No Abstract] [Full Text] [Related]
23. COVID-19 in rheumatic diseases in Italy: first results from the Italian registry of the Italian Society for Rheumatology (CONTROL-19). Scirè CA; Carrara G; Zanetti A; Landolfi G; Chighizola C; Alunno A; Andreoli L; Caporali R; Gerli R; Sebastiani GD; Valesini G; Sinigaglia L; Clin Exp Rheumatol; 2020; 38(4):748-753. PubMed ID: 32723435 [TBL] [Abstract][Full Text] [Related]
25. Frequency and severity of COVID-19 in patients treated with biological disease-modifying anti-rheumatic drugs for inflammatory rheumatic disease: a cross-sectional study. Lohse A; Bossert M; Bozgan AM; Charpentier A; Guillochon C; Bourgoin C; Balblanc JC; Conrozier T Clin Exp Rheumatol; 2020; 38(6):1273. PubMed ID: 33253100 [No Abstract] [Full Text] [Related]
26. Role of immunosuppressive therapy in rheumatic diseases concurrent with COVID-19. Lu C; Li S; Liu Y Ann Rheum Dis; 2020 Jun; 79(6):737-739. PubMed ID: 32295789 [No Abstract] [Full Text] [Related]
27. Your help is needed in the fight against COVID-19: Please contribute to the COVID-19 Global rheumatology alliance registry. Int J Rheum Dis; 2021 Jun; 24(6):860. PubMed ID: 34097357 [No Abstract] [Full Text] [Related]
28. COVID-19 pneumonia in a large cohort of patients treated with biological and targeted synthetic antirheumatic drugs. Conticini E; Bargagli E; Bardelli M; Rana GD; Baldi C; Cameli P; Gentileschi S; Bennett D; Falsetti P; Lanzarone N; Bellisai F; Barreca C; D'Alessandro R; Cantarini L; Frediani B Ann Rheum Dis; 2021 Feb; 80(2):e14. PubMed ID: 32414804 [No Abstract] [Full Text] [Related]
29. SLE patients are not immune to covid-19: importance of sending the right message across. Goyal M Ann Rheum Dis; 2021 Feb; 80(2):e23. PubMed ID: 32327426 [No Abstract] [Full Text] [Related]
30. Use of Tofacitinib in the Context of COVID-19 Vaccination: Comment on the American College of Rheumatology Clinical Guidance for COVID-19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases. Mortezavi M; Menon S; Lee K; Rivas J Arthritis Rheumatol; 2021 Sep; 73(9):1768-1769. PubMed ID: 34042319 [No Abstract] [Full Text] [Related]
31. How the COVID-19 pandemic has affected rheumatology research. Moreyra PA; Berenbaum F; Danda D; Grötsch B; Stones SR; Viswanathan S Nat Rev Rheumatol; 2022 Mar; 18(3):128-132. PubMed ID: 35017743 [TBL] [Abstract][Full Text] [Related]
32. [INTERNATIONAL COOPERATION IN PEDIATRIC RHEUMATOLOGY IN THE CORONA ERA]. Uziel Y Harefuah; 2021 May; 160(5):276-278. PubMed ID: 34028217 [TBL] [Abstract][Full Text] [Related]
33. COVID-19 and how evidence of a new disease evolves. Kroon FPB; Mikuls TR; Landewé RB Ann Rheum Dis; 2021 Mar; 80(3):401-402. PubMed ID: 32796046 [No Abstract] [Full Text] [Related]
34. [Vaccination against SARS-CoV-2 in inflammatory rheumatic diseases : Recommendations of the German Society for Rheumatology for physicians and patients]. Specker C; ; Schulze-Koops H; Z Rheumatol; 2021 Feb; 80(1):43-44. PubMed ID: 33438061 [No Abstract] [Full Text] [Related]
35. Managing patients with rheumatic diseases during the COVID-19 pandemic: The French Society of Rheumatology answers to most frequently asked questions up to May 2020. Richez C; Flipo RM; Berenbaum F; Cantagrel A; Claudepierre P; Debiais F; Dieudé P; Goupille P; Roux C; Schaeverbeke T; Wendling D; Pham T; Thomas T Joint Bone Spine; 2020 Oct; 87(5):431-437. PubMed ID: 32473418 [TBL] [Abstract][Full Text] [Related]
36. COVID-19 and rheumatology: is shielding really necessary? Amani L; Warraich R; Patel N; Tahir H Br J Hosp Med (Lond); 2020 Jun; 81(6):1-3. PubMed ID: 32589537 [TBL] [Abstract][Full Text] [Related]
37. Are my patients with rheumatic diseases at higher risk of COVID-19? Figueroa-Parra G; Aguirre-Garcia GM; Gamboa-Alonso CM; Camacho-Ortiz A; Galarza-Delgado DA Ann Rheum Dis; 2020 Jun; 79(6):839-840. PubMed ID: 32205336 [No Abstract] [Full Text] [Related]
38. Self-care recommendations for patients with rheumatic diseases during the COVID-19 pandemic. Kim HS; Lee MS; Kim H; Sung YK; Lee J; Shim SC; Park SH; Baek HJ Rheumatol Int; 2020 Aug; 40(8):1347-1349. PubMed ID: 32488428 [No Abstract] [Full Text] [Related]
39. Online management of rheumatoid arthritis during COVID-19 pandemic. Zhang Y; Wang J; Zhao L; Xiao J; Shi Z Ann Rheum Dis; 2021 Jan; 80(1):e4. PubMed ID: 32340979 [No Abstract] [Full Text] [Related]
40. Editorial: Rheumatology at the center of coronavirus disease 2019: pathogenesis, treatment, and clinical care. Haberman RH; Jaros BD; Scher JU Curr Opin Rheumatol; 2021 Sep; 33(5):409-411. PubMed ID: 34175865 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]